Literature DB >> 28690895

Discrimination Between Drug Abuse and Medical Therapy: Case report of a tranylcypromine overdose-related fatality.

Maryam Akhgari1, Farzaneh Jokar1, Afshar Etemadi-Aleagha2, Ali Ghasemi2.   

Abstract

Tranylcypromine is an effective antidepressant from the class of monoamine oxidase inhibitors and is structurally related to amphetamine. However, reports differ regarding the potential metabolism of tranylcypromine to amphetamine and methamphetamine within the human body. We report a 25-year-old woman with severe depression who died due to a fatal tranylcypromine overdose in 2016. She had been prescribed tranylcypromine one day previously and had no history of previous suicide attempts or substance abuse. The body was transferred to a forensic medicine department in Tehran, Iran for the autopsy. A urine sample was positive for tranylcypromine, amphetamine and methamphetamine using gas chromatography/mass spectrometry after derivatisation with heptafluorobutyric acid. As amphetamines were present in the urine sample, it was assumed that the tranylcypromine had been converted to amphetamines metabolically. As such, it is possible that the legitimate use of certain prescription drugs may complicate the interpretation of test results for illegal drugs.

Entities:  

Keywords:  Amphetamine; Case Report; Forensic Toxicology; Iran; Metabolism; Substance Abuse Detection; Tranylcypromine

Mesh:

Substances:

Year:  2017        PMID: 28690895      PMCID: PMC5488824          DOI: 10.18295/squmj.2016.17.02.013

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN: 2075-051X


  18 in total

1.  Failure to detect amphetamine or 1-amino-3-phenylpropane in humans or rats receiving the MAO inhibitor tranylcypromine.

Authors:  R L Sherry; G Rauw; K F McKenna; P R Paetsch; R T Coutts; G B Baker
Journal:  J Affect Disord       Date:  2000-12       Impact factor: 4.839

2.  METABOLISM OF TRANYLEYPROMINE-C14 AND DL AMPHETAMINE-C14 IN THE RAT.

Authors:  J J ALLEVA
Journal:  J Med Chem       Date:  1963-11       Impact factor: 7.446

Review 3.  Interindividual Variability in Cytochrome P450-Mediated Drug Metabolism.

Authors:  Timothy S Tracy; Amarjit S Chaudhry; Bhagwat Prasad; Kenneth E Thummel; Erin G Schuetz; Xiao-Bo Zhong; Yun-Chen Tien; Hyunyoung Jeong; Xian Pan; Laura M Shireman; Jessica Tay-Sontheimer; Yvonne S Lin
Journal:  Drug Metab Dispos       Date:  2015-12-17       Impact factor: 3.922

4.  The GCMS analysis of tranylcypromine (Parnate) in a suspected overdose.

Authors:  J Crifasi; C Long
Journal:  Forensic Sci Int       Date:  1997-04-18       Impact factor: 2.395

5.  Single-dose effects of tranylcypromine on psychophysiological measures in normals.

Authors:  V Gentil; B Alevizos; M Felix-Gentil; M Lader
Journal:  Br J Clin Pharmacol       Date:  1978-06       Impact factor: 4.335

Review 6.  Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation.

Authors:  Ulrich M Zanger; Matthias Schwab
Journal:  Pharmacol Ther       Date:  2013-01-16       Impact factor: 12.310

Review 7.  Drugs related to monoamine oxidase activity.

Authors:  Zdeněk Fišar
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2016-03-02       Impact factor: 5.067

8.  Quantitative determination of methamphetamine in oral fluid by liquid-liquid extraction and gas chromatography/mass spectrometry.

Authors:  L Bahmanabadi; M Akhgari; F Jokar; H B Sadeghi
Journal:  Hum Exp Toxicol       Date:  2016-07-11       Impact factor: 2.903

9.  Enantiospecific high-performance liquid chromatographic assay with fluorescence detection for the monoamine oxidase inhibitor tranylcypromine and its applicability in pharmacokinetic studies.

Authors:  H Spahn-Langguth; G Hahn; E Mutschler; W Möhrke; P Langguth
Journal:  J Chromatogr       Date:  1992-12-23

10.  Evaluation of cytochrome P450 2D6 phenotyping in healthy adult Western Indians.

Authors:  Nithya J Gogtay; Nitin B Mali; Krishna Iyer; Prashant P Kadam; Kannan Sridharan; Divya Shrimal; Urmila M Thatte
Journal:  Indian J Pharmacol       Date:  2014 May-Jun       Impact factor: 1.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.